Edition:
India

Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

11.82HKD
11 Dec 2017
Change (% chg)

HK$0.62 (+5.54%)
Prev Close
HK$11.20
Open
HK$11.20
Day's High
HK$11.96
Day's Low
HK$11.20
Volume
47,753,570
Avg. Vol
19,830,093
52-wk High
HK$11.96
52-wk Low
HK$5.23

Latest Key Developments (Source: Significant Developments)

Sino Biopharmaceutical Product Granted Drug Registration Approval By State FDA Of China​
Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::"TENOFOVIR DISOPROXIL FUMARATE TABLET" GRANTED DRUG REGISTRATION APPROVAL BY STATE FOOD AND DRUG ADMINISTRATION OF CHINA​.‍TENOFOVIR DISOPROXIL FUMARATE GRANTED APPROVAL FOR TREATMENT OF CHRONIC HEPATITIS B​.  Full Article

Sino Biopharmaceutical posts 9-month ‍net profit attributable of RMB1.80​ bln
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK> ::9-month ‍revenue RMB11,446.73 million, up 9.5​ percent.‍Declared payment of a third quarterly dividend of HK2 cents per share for three months ended 30 Sept​.9-month net profit attributable to owners RMB1.80​ billion versus RMB1.30 billion.  Full Article

Sino biopharmaceutical enters into a facility agreement
Wednesday, 28 Sep 2016 

Sino Biopharmaceutical Ltd <1177.HK> : Loan facility in an aggregate principal amount of US$300 million . Company, as borrower, entered into a facility agreement with original lenders . Original lenders have agreed to make available to company a dual tranche three-year term loan facility .Amount borrowed under loan facility will be used by company for refinancing of existing loans owed by company.  Full Article

Sino Biopharmaceutical says there was fire in treatment plant at Lianyungang<1177.HK>
Thursday, 1 Sep 2016 

Sino Biopharmaceutical Ltd <1177.HK>: On 27 August 2016, there was a fire in an used waste solvent treatment plant at Lianyungang, PRC . Accident did not extend to production plants and the subsidiary has resumed full production . Expects the incident does not have any material impact on the group's general operation, financial position and cash flows. . There were damages to certain properties and facilities of the subsidiary .  Full Article

Sino Biopharmaceutical HY net profit of hk$1.01 bln versus hk$928.2 mln a year ago<1177.HK>
Friday, 26 Aug 2016 

Sino Biopharmaceutical Ltd <1177.HK>: Interim results announcement for the six months ended 30 June, 2016 <1177.HK> . HY net profit of hk$1.01 billion versus hk$928.2 million a year ago . HY revenue was approximately hk$8.04 billion, an increase of approximately 8.0% . Declared payment of a second quarterly dividend of hk1.5 cents per share for three months ended 30 June . Believes the pharmaceutical industry will develop as a whole in a healthier and more standardized manner" .  Full Article

Sino Biopharmaceutical appoints Tse Ping as CEO<1177.HK>
Friday, 29 Jul 2016 

Sino Biopharmaceutical Ltd <1177.HK>: Resignation of executive director and change of chief executive officer <1177.HK> . Tse Ping, an executive director of the company, has been appointed as the Chief Executive Officer of the company . Says Xu Xiaoyang tendered his resignation as executive director,and Chief Executive Officer .  Full Article

Sino Biopharmaceutical posts qtrly profit attributable HK$528 million<1177.HK>
Wednesday, 18 May 2016 

Sino Biopharmaceutical Ltd <1177.HK>: First quarterly results announcement for the three months ended 31 March, 2016 <1177.HK> . Qtrly profit attributable hk$ 528 million versus hk$400.0 million . Qtrly revenue was approximately hk$4.17 billion, an increase of approximately 11.6% over the same period last year . Declared the payment of a quarterly dividend of hk1.5 cents per share for the three months ended 31 March, 2016 .  Full Article

BRIEF-Sino Biopharmaceutical Product Granted Drug Registration Approval By State FDA Of China​

* "TENOFOVIR DISOPROXIL FUMARATE TABLET" GRANTED DRUG REGISTRATION APPROVAL BY STATE FOOD AND DRUG ADMINISTRATION OF CHINA​